A-Fib Catheter Ablation Cuts Risk for Ischemic Stroke After 30 Days, Mortality, Heart Failure Hospitalization
By Elana Gotkine HealthDay Reporter
MONDAY, July 7, 2025 -- For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, mortality, and heart failure hospitalization, while surgical ablation only reduces stroke risk, according to a review published online July 1 in the Annals of Internal Medicine.
Bryce Montane, M.D., from Washington University in St. Louis, and colleagues examined the effect of ablation on several outcomes, including ischemic stroke, mortality, and heart failure hospitalization in a review of randomized controlled trials of catheter or surgical ablation versus no ablation that had at least one month of follow-up.
The researchers found that catheter ablation reduced risks for ischemic stroke after 30 days, mortality, and heart failure hospitalization compared with medical therapy (relative risks [95 percent confidence intervals], 0.63 [0.43 to 0.92], 0.73 [0.60 to 0.88], and 0.68 [0.55 to 0.85], respectively). However, catheter ablation also increased the relative risk for ischemic stroke at or before 30 days (relative risk, 6.81; 95 percent confidence interval, 1.56 to 29.8), such that the relative risks (95 percent confidence intervals) for ischemic stroke and stroke from any cause were 0.77 (0.55 to 1.09) and 0.77 (0.57 to 1.05). Surgical ablation reduced the relative risks (95 percent confidence intervals) for ischemic stroke and stroke from any cause (0.54 [0.34 to 0.86] and 0.54 [0.35 to 0.82]); for other outcomes, benefits were uncertain.
"Catheter ablation reduced the risks for ischemic stroke after 30 days, mortality, and heart failure hospitalization," the authors write. "Surgical ablation reduced risks for ischemic stroke and strokes from any cause but had uncertain benefit for other outcomes."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
Low Rates of Isolated Locoregional Recurrence Seen in Young Women With Breast Cancer
TUESDAY, July 29, 2025 -- For women diagnosed with breast cancer at age 40 years or younger, the risk for isolated locoregional recurrence (LRR) is relatively low, according to a...
Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery
TUESDAY, July 29, 2025 -- Opioid-limiting pain management education and counseling reduce opioid consumption with no increase in postoperative pain among patients undergoing...
Risk-Reducing Mastectomy Cost-Effective With Breast Cancer Risk ≥35 Percent
MONDAY, July 28, 2025 -- Undergoing risk-reducing mastectomy (RRM) seems to be cost-effective for women aged 30 to 55 years with a lifetime breast cancer (BC) risk of 35 percent...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.